ArticleScientific reports2026
First time exploration and characterization of key-intermediates in palladium-catalysed coupling reactions.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The oxidative addition of a bromoporphyrin onto in situ formed highly active Pd(0) complex allowed us to characterize the Pd(II) intermediate by X-ray crystallography. In addition, after the heterobidentate coordination of Xantphos hemioxide (Xantphos: 4,5-bis(diphenylphosphino)-9,9-dimethyl-xanthene), the oxidized product responsible for Pd(II)-Pd(0) reduction, was also proved. The species isolated by us is the product of oxidative addition, the first step of the suggested catalytic cycle. Earlier only the structure of the dichloro complex of palladium with (P-P(O)) ligand was known. The isolated Pd(P-P(O))X(porphyrinyl) complex can be considered as a new example of catalytic intermediates of important cross-coupling and carbonylation reactions giving further strong proof for their mechanism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.